See All Slides - tctmd.com

Slides

Presentation TCT 2013

REPRISE II: A Prospective Registry Study of Transcatheter Aortic Valve Replacement with a Repositionable Transcatheter Heart Valve in Patients with Severe Aortic Stenosis

Presenter: Ian Meredith

October 31, 2013

Presentation TCT 2013

Pulmonary Embolism: When to Use Lytics, When to Use Novel Oral Anticoagulants

Presenter: Ori Ben-Yehuda

October 31, 2013

Presentation TCT 2013

Any Dedicated Valve Therapist with Hands-on TAVR Experience Can Provide Accurate Risk Assessment!

Presenter: Augusto Pichard

October 31, 2013

Presentation TCT 2013

Radial Access: Troubleshooting and Vascular Complications

Presenter: Scott Harding

October 31, 2013

Presentation TCT 2013

Therapeutic Options for Coronary Thrombus

Presenter: Holger Thiele

October 31, 2013

Presentation TCT 2013

Interventional Management of Cardiogenic Stroke

Presenter: Robert Sommer

October 31, 2013

Presentation TCT 2013

Outcomes of Patients Treated with Triple Antithrombotic Therapy After Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction (From the Harmonizing...

Presenter: Eugenia Nikolsky

October 31, 2013

Presentation

Bringing It All Together for Device Development/Education and Technique Optimization

Presenter: Liz Perpetua

October 31, 2013

Presentation TCT 2013

Genetic Testing for 9p21 can Cost Effectively Reduce Cardiovascular Events

Presenter: James Devlin

October 31, 2013

Presentation TCT 2013

Case #3: Left Main + Ostial LAD (Medina 1,1,0)

Presenter: Jeffrey Moses

October 31, 2013

Advertisement

Slides

REPRISE II: A Prospective Registry Study of Transcatheter Aortic Valve Replacement with a Repositionable Transcatheter Heart Valve in Patients with Severe Aortic Stenosis

Pulmonary Embolism: When to Use Lytics, When to Use Novel Oral Anticoagulants

Any Dedicated Valve Therapist with Hands-on TAVR Experience Can Provide Accurate Risk Assessment!

Radial Access: Troubleshooting and Vascular Complications

Therapeutic Options for Coronary Thrombus

Interventional Management of Cardiogenic Stroke

Outcomes of Patients Treated with Triple Antithrombotic Therapy After Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction (From the Harmonizing...

Bringing It All Together for Device Development/Education and Technique Optimization

Genetic Testing for 9p21 can Cost Effectively Reduce Cardiovascular Events

Case #3: Left Main + Ostial LAD (Medina 1,1,0)

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content